Merck (MRK) Net Margin (2009 - 2026)

Merck (MRK) reported Net Margin of 25.84% for Q1 2026, down 5859.0% year-over-year from 0.45% in Q1 2025, and down 243.09% quarter-over-quarter from 18.06% in Q4 2025.

Merck (MRK) Net Margin (2009 - 2026) Analysis & Trends

Merck (MRK) has 17 years of Net Margin data on file, last reported at 25.84% in Q1 2026.

  • Net Margin for Q1 2026 came in at 25.84%, down 5859.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 13.64% (down 1366.0% YoY), and the FY2025 annual result was 28.09%, up 139.0% from the prior year.
  • Net Margin declined to 25.84% in Q1 2026 per MRK's latest filing, from 18.06% in the prior quarter.
  • Over five years, Net Margin peaked at 33.89% in Q2 2024 and troughed at 39.49% in Q2 2023.
  • A 4-year average of 14.99% and a median of 23.96% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2024 and 2026: Net Margin surged 7338 bps in 2024, then tumbled 5859 bps in 2026.
  • A 4-year view of Net Margin shows it stood at 8.38% in 2023, then jumped by 386 bps to 23.96% in 2024, then decreased by 25 bps to 18.06% in 2025, then tumbled by 243 bps to 25.84% in 2026.
  • Business Quant data shows MRK's Net Margin at 25.84% in Q1 2026, 18.06% in Q4 2025, and 33.5% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 22.77%
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 37.36%
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 21.76%
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 4.65%
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -25.84%
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 21.11%
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 29.04%
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -0.56%
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 23.32%
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.84%
Dec 31, 2025 18.06%
Sep 30, 2025 33.50%
Jun 30, 2025 28.01%
Mar 31, 2025 32.75%
Dec 31, 2024 23.96%
Sep 30, 2024 18.98%
Jun 30, 2024 33.89%
Mar 31, 2024 30.22%
Dec 31, 2023 -8.38%
Sep 30, 2023 29.76%
Jun 30, 2023 -39.49%
Mar 31, 2023 19.50%
Dec 31, 2021 -0.46%
Jun 30, 2021 2.91%
Mar 31, 2021 4.11%
Dec 31, 2020 4.78%
Sep 30, 2020 5.65%
Jun 30, 2020 7.07%
Mar 31, 2020 26.70%